Expansion and Upgrades SCIEX is actively expanding and upgrading its platform, including ASMS 2026 announcements of ZenoTOF line enhancements and broad platform-wide advancements. This signals ongoing investment in cutting-edge mass spectrometry solutions, presenting opportunities to upsell the latest ZenoTOF capabilities, software, and service packages to existing customers and new proteomics labs.

Strategic Partnerships Recent collaboration with Ion Opticks to expand access to advanced LC solutions for proteomics highlights a pathway for co-sell or bundled offerings. This creates a sales angle to propose integrated LC-MS workflows, Aurora XS columns, and joint service/support arrangements to labs focusing on high-throughput proteomics.

High-Value Market With revenue in the multi-billion range and a global footprint, SCIEX serves major segments including drug discovery, food and environmental testing, forensics, and clinical research. Targeted opportunities exist in R&D labs seeking reliable, high-sensitivity analytical platforms and value-add services to accelerate projects in those verticals.

Innovation and Software Introduction of OS software version 4.0 to improve automation and processing speeds indicates a customer need for streamlined workflows. This presents cross-sell opportunities for automation modules, data processing add-ons, and training services to customers adopting newer hardware and software ecosystems.

Impactful Services Given SCIEX’s emphasis on world-class service and support and the acquisition activity in the ecosystem, there is an opening for extended service contracts, remote monitoring, and performance optimization engagements. Propose proactive maintenance packages, performance tuning, and lifecycle management to maximize uptime for critical analytical instruments.